CoChat

Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 1 of the 10 sources its claims cite were checked for support.

Abstract

Study showing differential recognition of VAR2CSA domains by naturally acquired antibodies in pregnant women in a malaria endemic area, with parity-related patterns.

Overview

CoChat Summary

TL;DR

This study found that antibodies to the VAR2CSA DBL5ε domain in pregnant Malawian women increased with parity and correlated with antibodies to placental parasite surface antigens, supporting DBL5ε as a vaccine candidate for pregnancy-associated malaria. HIV co-infection was associated with lower anti-DBL5ε IgG levels, and in primigravidae it was also associated with lower antibody affinity to DBL5ε.

Key findings

  • In 189 primigravidae, 21 secundigravidae, and 72 multigravidae, multigravid women had significantly higher levels of VSA-PAM antibodies than primigravid women (Kruskal-Wallis ANOVA, p = 0.0001; Dunn’s test, p<0.001).
  • DBL5ε showed the clearest parity-dependent recognition: multigravid women had higher anti-DBL5ε antibodies than primigravidae (Kruskal-Wallis ANOVA, p = 0.0141; Dunn’s test, p<0.05), and anti-DBL5ε levels correlated with VSA-PAM antibodies (Spearman r = 0.5632, p<0.0001).
  • HIV-positive women had lower anti-DBL5ε IgG than HIV-negative women of similar parity; this difference was significant in multigravidae (p = 0.023). In primigravidae, HIV-positive women also had lower affinity to DBL5ε, with higher dissociation rate constant kd (t-test, p = 0.0230).
  • Anti-DBL5ε levels and total VSA-PAM antibodies correlated with parasitemia in some groups, including VSA-PAM vs parasitemia overall (Spearman r = 0.2134, p = 0.0005) and DBL5ε vs parasitemia in primigravidae (r = 0.2000, p = 0.0123).

Methods

  • Pregnant women attending Queen Elizabeth Central Hospital in Blantyre, Malawi were enrolled in late third trimester; serum samples were analyzed from 189 primigravidae, 21 secundigravidae, and 72 multigravidae.
  • Flow cytometry on CS2 infected red blood cells measured antibodies to VSA-PAM, and CHO-745 cells expressing VAR2CSA DBL domains were used to quantify domain-specific IgG.
  • Surface plasmon resonance on recombinant FCR3 VAR2CSA DBL5ε measured dissociation rate constants (kd) as an indicator of antibody affinity; statistical tests included Kruskal-Wallis ANOVA with Dunn’s post hoc tests, Spearman correlations, and t-tests.

Limitations

  • The paper explicitly notes that only a “convenience selection” of stored serum samples was used, which limits representativeness.
  • The text makes evident that sample sizes were uneven across parity groups, especially the small secundigravidae group (21), which may reduce power for subgroup comparisons.
  • The paper does not report the results of some assays in full in the provided text, so some detailed outcomes are not stated in the paper excerpt.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0009230

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 VSA-PAM and VAR2CSA DBL-domain recognition of naturally acquired antibodies in pregnant women. A: IgG levels against VSA-PAM expressed on the surface of CS2 parasites. Groups are divided into primigravidae (PG), secundigravidae (SG) and multigravidae (MG) (x-axis) and antibody levels are expressed as relative median fluorescence intensity (rMFI, y-axis). MG women have significantly higher levels of antibodies against VSA-PAM than PG women (Kruskal-Wallis ANOVA, p = 0.0001; Dunn's Multiple Comparison test, p<0.001). B: IgG levels against VAR2CSA domains DBL3x (n = 93 pregnancy and 10 male sera), DBL5ε (n = 125 pregnancy and 13 male sera), and DBL6ε (n = 122 pregnancy and 9 male sera), Groups are divided into pregnant women (all parities shown together, labeled P) and males (labeled M) from the same endemic areas. Pregnant women had significantly higher levels of antibodies against each domain than their male counterparts, except for DBL3x, probably due to the lower sample size for this domain (Kruskal-Wallis ANOVA, p<0.0001; Dunn's Multiple Comparison test, p>0.05 (ns) (DBL3x), p<0.01 (DBL5ε) and p = 0.05 (DBL6ε)). C: IgG levels against DBL3x showing no significant difference in antibody levels in PG and MG women (Kruskal-Wallis ANOVA, p = 0.0589). D: Correlation of IgG levels against DBL3x and total VSA-PAM, expressed as rMFI. No correlation was found (Spearman r = −0.08980, p = 0.3972). E: IgG levels against DBL5ε showing significantly higher levels of antibodies in MG women than PG women (Kruskal-Wallis ANOVA, p = 0.0141, Dunn's Multiple Comparison test, p<0.05). F: Correlation of IgG levels against DBL5ε and total VSA-PAM, expressed as rMFI. A significant positive moderate correlation was found (Spearman r = 0.5632, p<0.0001). G: IgG levels against DBL6ε showing no significant difference in antibody levels in PG and MG women (Kruskal-Wallis ANOVA, p = 0.5118). H: Correlation of IgG levels against DBL6ε and total VSA-PAM, expressed as rMFI. A significant positive weak correlation was found (Spearman r = 0.2905, p = 0.0013).
Figure 1 VSA-PAM and VAR2CSA DBL-domain recognition of naturally acquired antibodies in pregnant women. A: IgG levels against VSA-PAM expressed on the surface of CS2 parasites. Groups are divided into primigravidae (PG), secundigravidae (SG) and multigravidae (MG) (x-axis) and antibody levels are expressed as relative median fluorescence intensity (rMFI, y-axis). MG women have significantly higher levels of antibodies against VSA-PAM than PG women (Kruskal-Wallis ANOVA, p = 0.0001; Dunn's Multiple Comparison test, p<0.001). B: IgG levels against VAR2CSA domains DBL3x (n = 93 pregnancy and 10 male sera), DBL5ε (n = 125 pregnancy and 13 male sera), and DBL6ε (n = 122 pregnancy and 9 male sera), Groups are divided into pregnant women (all parities shown together, labeled P) and males (labeled M) from the same endemic areas. Pregnant women had significantly higher levels of antibodies against each domain than their male counterparts, except for DBL3x, probably due to the lower sample size for this domain (Kruskal-Wallis ANOVA, p<0.0001; Dunn's Multiple Comparison test, p>0.05 (ns) (DBL3x), p<0.01 (DBL5ε) and p = 0.05 (DBL6ε)). C: IgG levels against DBL3x showing no significant difference in antibody levels in PG and MG women (Kruskal-Wallis ANOVA, p = 0.0589). D: Correlation of IgG levels against DBL3x and total VSA-PAM, expressed as rMFI. No correlation was found (Spearman r = −0.08980, p = 0.3972). E: IgG levels against DBL5ε showing significantly higher levels of antibodies in MG women than PG women (Kruskal-Wallis ANOVA, p = 0.0141, Dunn's Multiple Comparison test, p<0.05). F: Correlation of IgG levels against DBL5ε and total VSA-PAM, expressed as rMFI. A significant positive moderate correlation was found (Spearman r = 0.5632, p<0.0001). G: IgG levels against DBL6ε showing no significant difference in antibody levels in PG and MG women (Kruskal-Wallis ANOVA, p = 0.5118). H: Correlation of IgG levels against DBL6ε and total VSA-PAM, expressed as rMFI. A significant positive weak correlation was found (Spearman r = 0.2905, p = 0.0013).CC BY · PubMed Central
Figure 2 The effect of HIV infection on antibody levels to DBL5ε. IgG levels against DBL5ε showing HIV negative women to have higher antibody levels than HIV positive women in all parity groups, however only significantly so in multigravidae (Kruskal-Wallis ANOVA, p = 0.023). Groups are divided into primigravidae (PG), secundigravidae (SG) and multigravidae (MG) and HIV positive (+) or negative (−) (x-axis) and antibody levels are expressed as relative median fluorescence intensity (rMFI, y-axis).
Figure 2 The effect of HIV infection on antibody levels to DBL5ε. IgG levels against DBL5ε showing HIV negative women to have higher antibody levels than HIV positive women in all parity groups, however only significantly so in multigravidae (Kruskal-Wallis ANOVA, p = 0.023). Groups are divided into primigravidae (PG), secundigravidae (SG) and multigravidae (MG) and HIV positive (+) or negative (−) (x-axis) and antibody levels are expressed as relative median fluorescence intensity (rMFI, y-axis).CC BY · PubMed Central
Figure 3 Affinity of naturally acquired antibodies in pregnant women to VAR2CSA DBL5ε. A: Affinity displayed as the dissociation rate constant (kd×10∧-4), comparing PG and MG (both HIV positive (+) and HIV negative (−) women). There is no significant difference between antibody affinities to DBL5ε comparing PG and MG women (t-test, p = 0.7630). B: Affinity displayed as the dissociation rate constant (kd×10∧-4), comparing primigravid women divided into HIV status. Antibodies from PG HIV- women have a significantly higher affinity to DBL5ε than antibodies from PG HIV+ women (t-test, p = 0.0230). C: Affinity displayed as the dissociation rate constant (kd×10∧-4), comparing multigravid women divided into HIV status. No significant difference in antibody affinity is seen comparing groups MG- women and MG+ women (t-test, p = 0.1152).
Figure 3 Affinity of naturally acquired antibodies in pregnant women to VAR2CSA DBL5ε. A: Affinity displayed as the dissociation rate constant (kd×10∧-4), comparing PG and MG (both HIV positive (+) and HIV negative (−) women). There is no significant difference between antibody affinities to DBL5ε comparing PG and MG women (t-test, p = 0.7630). B: Affinity displayed as the dissociation rate constant (kd×10∧-4), comparing primigravid women divided into HIV status. Antibodies from PG HIV- women have a significantly higher affinity to DBL5ε than antibodies from PG HIV+ women (t-test, p = 0.0230). C: Affinity displayed as the dissociation rate constant (kd×10∧-4), comparing multigravid women divided into HIV status. No significant difference in antibody affinity is seen comparing groups MG- women and MG+ women (t-test, p = 0.1152).CC BY · PubMed Central
Figure 4 Correlation of VSA-PAM IgG, DBL5ε IgG and antibody affinity. A: Correlation of IgG levels against total VSA-PAM and antibody affinity against DBL5ε, expressed as rMFI and dissociation rate constant respectively. These show a negative moderate significant correlation (Spearman r = −0.3571, p = 0.0002). B: Correlation of IgG levels against DBL5ε and antibody affinity against DBL5ε, expressed as rMFI and dissociation rate constant respectively. These show a negative moderate significant correlation (Spearman r = −0.3414, p = 0.0024).
Figure 4 Correlation of VSA-PAM IgG, DBL5ε IgG and antibody affinity. A: Correlation of IgG levels against total VSA-PAM and antibody affinity against DBL5ε, expressed as rMFI and dissociation rate constant respectively. These show a negative moderate significant correlation (Spearman r = −0.3571, p = 0.0002). B: Correlation of IgG levels against DBL5ε and antibody affinity against DBL5ε, expressed as rMFI and dissociation rate constant respectively. These show a negative moderate significant correlation (Spearman r = −0.3414, p = 0.0024).CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 0 Not valid · 9 Not checked · 25 Own results and interpretations

18 more claims

Create a free account to see all 35 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 11
  • Probably not a substantial claim. 3

Create a free account to see these claims.

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. A Salanti, 2004, Evidence for the involvement of VAR2CSA in pregnancy-associated malaria., J Exp Med, 200, 1197, 10.1084/jem.20041579 · DOI · Paper page

Cited by

See all 24

Metadata

Authors
Brolin, K. J. M., Persson, K. E. M., Wahlgren, M., Rogerson, S. J., & Chen, Q.
Affiliations
  • Swedish Institute (SE)
  • The Royal Melbourne Hospital (AU)
  • Jilin University (CN)
Corresponding author
  • Rogerson, Stephen J.
  • Chen, Qijun
Venue
PLoS ONE
Published
2010-02-16
Volume
5
Issue
2
Pages
e9230
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2068387678
Cited by
24
References
44
Citations by year
2025: 1 · 2023: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 3 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 2
FWCI
1.90
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Styrelsen för Internationellt Utvecklingssamarbete
  • Wenner-Gren Stiftelserna
  • Boehringer Ingelheim Fonds
  • National Institutes of Health
  • U.S. Public Health Service (A149084)
  • Medical Research Council
  • National Health and Medical Research Council
  • National Key Research and Development Program of China (2007CB513100)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords
Plasmodium falciparum, VAR2CSA, malaria in pregnancy, placental sequestration, variant surface antigens, naturally acquired antibodies, HIV coinfection, antibody affinity, vaccine candidate, primigravida, pregnant women
MeSH terms
Adult, Animals, Antibodies, Antibody Affinity, Epitopes, Antigens, Protozoan, Binding Sites, Cricetulus, Female, Flow Cytometry, Cricetinae, Humans, Immunoglobulin G, Malawi, Pregnancy, Pregnancy Complications, Parasitic, HIV Infections, Comorbidity, CHO Cells, Malaria, Falciparum, Endemic Diseases, Gravidity, Surface Plasmon Resonance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area. https://app.cochat.ai/papers/10.1371/journal.pone.0009230
The paper
Brolin, K. J. M., Persson, K. E. M., Wahlgren, M., Rogerson, S. J., & Chen, Q. (2010). Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area. PLoS ONE. https://doi.org/10.1371/journal.pone.0009230

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.